Prospective, randomized, double-blind, double-dummy, active-controlled, phase 3 clinical trial comparing the safety and efficacy of intranasal dexmedetomidine to oral midazolam as premedication for propofol sedation in pediatric patients undergoing magnetic resonance imaging: the MIDEX MRI trial.
Olivia Nzungu WabeloDenis SchmartzMario GiancursioFrançoise De PooterGiulia CarusoJean-François FilsPhilippe Van der LindenPublished in: Trials (2023)
ClinicalTrial.gov NCT05192629 . Registered on 14 January 2022. Protocol version 2.1.
Keyphrases
- magnetic resonance imaging
- double blind
- phase iii
- clinical trial
- placebo controlled
- phase ii
- patients undergoing
- contrast enhanced
- study protocol
- open label
- randomized controlled trial
- diffusion weighted imaging
- computed tomography
- psychometric properties
- cardiac surgery
- molecularly imprinted
- mechanical ventilation
- magnetic resonance
- mass spectrometry
- young adults
- childhood cancer